Home › Acute Myeloid Leukemia › New York › Albany
Acute Myeloid Leukemia clinical trials in Albany, NY
3 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Albany (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RecruitingPhase 3
- Albany Medical Center, Albany
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
RecruitingPhase 3
- Albany Medical Center, Albany
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Albany Medical Center, Albany
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX85 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Baldwin Park, CA40 studies
- Seattle, WA40 studies
- Columbus, OH35 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Atlanta, GA30 studies
- Tampa, FL29 studies
- Chicago, IL26 studies
- Portland, OR25 studies
Other studies in Albany
- Non-Small Cell Lung Cancer9 studies
- Cardiovascular Disease7 studies
- Obesity6 studies
- Heart Failure6 studies
- Cancer (all types)5 studies
- Burkitt Lymphoma4 studies
- High Blood Pressure4 studies
- Bladder Cancer4 studies
- Metastatic Cancer4 studies
- Prostate Cancer4 studies
- Multiple Myeloma4 studies
- Digestive Diseases4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.